Porth Ymchwil

A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. / Hughes, D.; Verhoef, T.I.; Redekop, W.K. et al.
Yn: Pharmacogenomics, Cyfrol 11, Rhif 7, 01.07.2010, t. 989-1002.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Verhoef, TI, Redekop, WK, Darba, J, Geitona, M, Hughes, DA, Siebert, U, de Boer, A, Maitland-van der Zee, AH, Barallon, R, Briz, M, Daly, A, Haschke-Becher, E, Kamali, F, Kirchheiner, J, Manolopoulos, VG, Pirmohamed, M, Rosendaal, FR, van Schie, RM & Wadelius, M 2010, 'A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives', Pharmacogenomics, cyfrol. 11, rhif 7, tt. 989-1002. https://doi.org/10.2217/pgs.10.74

APA

Hughes, D., Verhoef, T. I., Redekop, W. K., Darba, J., Geitona, M., Hughes, D. A., Siebert, U., de Boer, A., Maitland-van der Zee, A. H., Barallon, R., Briz, M., Daly, A., Haschke-Becher, E., Kamali, F., Kirchheiner, J., Manolopoulos, V. G., Pirmohamed, M., Rosendaal, F. R., van Schie, R. M., & Wadelius, M. (2010). A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics, 11(7), 989-1002. https://doi.org/10.2217/pgs.10.74

CBE

Hughes D, Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA, Siebert U, de Boer A, Maitland-van der Zee AH, Barallon R, et al. 2010. A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics. 11(7):989-1002. https://doi.org/10.2217/pgs.10.74

MLA

Hughes, D. et al. "A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives". Pharmacogenomics. 2010, 11(7). 989-1002. https://doi.org/10.2217/pgs.10.74

VancouverVancouver

Hughes D, Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA et al. A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics. 2010 Gor 1;11(7):989-1002. doi: 10.2217/pgs.10.74

Author

Hughes, D. ; Verhoef, T.I. ; Redekop, W.K. et al. / A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Yn: Pharmacogenomics. 2010 ; Cyfrol 11, Rhif 7. tt. 989-1002.

RIS

TY - JOUR

T1 - A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

AU - Hughes, D.

AU - Verhoef, T.I.

AU - Redekop, W.K.

AU - Darba, J.

AU - Geitona, M.

AU - Hughes, D.A.

AU - Siebert, U.

AU - de Boer, A.

AU - Maitland-van der Zee, A.H.

AU - Barallon, R.

AU - Briz, M.

AU - Daly, A.

AU - Haschke-Becher, E.

AU - Kamali, F.

AU - Kirchheiner, J.

AU - Manolopoulos, V.G.

AU - Pirmohamed, M.

AU - Rosendaal, F.R.

AU - van Schie, R.M.

AU - Wadelius, M.

PY - 2010/7/1

Y1 - 2010/7/1

U2 - 10.2217/pgs.10.74

DO - 10.2217/pgs.10.74

M3 - Article

VL - 11

SP - 989

EP - 1002

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1744-8042

IS - 7

ER -